Key result
Higher Modified Fisher grade is linked to ~2.9-fold higher odds of post-SAH cerebral vasospasm.
Why the study?
Early identification of risk factors for cerebral vasospasm after subarachnoid hemorrhage is essential for timely intervention and improved outcomes in intensive care, but evidence synthesis was needed to inform nursing care strategies.
Systematic Review and Meta-Analysis (n=19,033)
Odds Ratio: 2.88 (95% CI 2.04–4.07)
Clinical severity scales, particularly the Modified Fisher and Fisher grades, along with hemodynamic status, are the strongest predictors of cerebral vasospasm following subarachnoid hemorrhage.
May aid vasospasm risk stratification after subarachnoid hemorrhage; leaves open need for prospective validation before changing practice.
BACKGROUND: Subarachnoid hemorrhage (SAH) is a life-threatening condition often leading to complications such as cerebral vasospasm, which causes delayed cerebral ischemia and increases mortality. In intensive care, early identification of vasospasm risk factors by nurses is essential for timely intervention and improved outcomes. OBJECTIVES: We sought to review and synthesize evidence on risk factors associated with cerebral vasospasm after SAH and inform early risk assessment and nursing care strategies in intensive care. METHODS: We conducted a systematic review and meta-analysis of observational studies. A comprehensive search was conducted on August 30 to 31, 2024, across 8 databases. Quality was assessed using the Joanna Briggs Institute checklist and the Risk of Bias (RoB 2.0) tool. RESULTS: Thirty-eight studies were included in the systematic review, of which 27 were included in the meta-analysis, involving 19 033 patients. Clinical severity measures were most strongly associated with cerebral vasospasm, including Modified Fisher grade (odds ratio (OR) = 2.88; 95% confidence interval (CI), 2.04-4.07), Fisher grade (OR = 2.27; 95% CI, 1.91-2.69), and hemodynamic status (OR = 2.56; 95% CI, 1.17-5.59). Aneurysm-related factors and comorbid conditions were associated with increased risk of cerebral vasospasm, whereas clinical biomarkers and inflammatory markers showed relatively smaller effect sizes. CONCLUSIONS: Clinical severity scales and hemodynamic status are the strongest predictors of cerebral vasospasm following SAH. These findings support early risk stratification and the implementation of structured monitoring strategies to improve patient outcomes.PROSPERO trial registration number:CRD42024605605 (https://www.crd.york.ac.uk/PROSPERO/view/CRD42024605605).
No takes yet. Share an insight, caveat, or question.
Koo et al. (2026) conducted a systematic review and meta-analysis in Subarachnoid hemorrhage (n=19,033). Clinical severity measures (Modified Fisher grade) was evaluated on Cerebral vasospasm (OR 2.88, 95% CI 2.04-4.07). Clinical severity measures strongly predicted cerebral vasospasm following subarachnoid hemorrhage, particularly the Modified Fisher grade (OR 2.88; 95% CI 2.04-4.07).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: